Faculty profile

Stephen Pasternak

Back to faculty

Associate Scientist, RobartsClinical Neurological SciencesWestern University

Stephen Pasternak

Associate Scientist, Robarts

Clinical Neurological Sciences

Schulich School of Medicine & Dentistry

Western University

London, Ontario, Canada

Supervision signals

This is a research or leadership role; ask the department whether it includes supervision.
6 publications in the last five years, latest in 2025.
Principal investigator on 4 research grants (4 CIHR), most recently in 2024.
Supervisor on 3 trainee awards (3 CIHR), most recently in 2024.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their Western University profile.

Alzheimer'S Disease Cell Biology Live Cell Imaging Blood Biomarker Dementia Diagnostics Pet Imaging Phosphorylated Tau

Latest papers

Regional free-water diffusion is more strongly related to neuroinflammation than neurodegeneration
Journal of Neurology · 2025
Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial.
The journal of prevention of Alzheimer's disease · 2025
White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases
Alzheimer's Research and Therapy · 2023

All 11 publications

Latest funding

Using circulating microglia extracellular vesicles to discriminate microglia activation phenotype, and cognitive outcomes in comorbid AD and stroke
CIHR · 2026 · Co-investigator
$1,227,826
Precision therapeutics for genetic disorders with transfer ribonucleic acids
CIHR · 2024 · Co-investigator
$1,067,175
Developing Novel Brain Imaging and Blood Testing Against a Major Early Disease Driver for Timely Diagnosis and Effective Treatment of Age-Dependent Tauopathies
CIHR · 2024 · Principal investigator
$1,075,000

All 11 grants and awards

11 publications.

Regional free-water diffusion is more strongly related to neuroinflammation than neurodegeneration

Sumra V, Hadian M, Dilliott AA, Farhan SMK, Frank AR, Lang AE, Roberts AC, Troyer A, Arnott SR, Marras C

Journal of Neurology202514 citations

DOI: 10.1007/s00415-025-13201-1

Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial.

Macfarlane S, Grimmer T, Teo K, O'Brien TJ, Woodward M, Grunfeld J, Mander A, Brodtmann A, Brew BJ, Morris P, Short C, Kurrle S, Lai R, Bharadwaj S, Drysdale P, Sturm J, Lewis SJG, Barton D, Kalafatis C, Sharif S, Perry R, Mannering N, MacSweeney JE, Pearson S, Evans C, Krishna V, Thompson A, Munisamy M, Bhatt N, Asher A, Connell S, Lynch J, Rutgers SM, Dautzenberg PL, Prins N, Oschmann P, Frölich L, Tacik P, Peters O, Wiltfang J, Henri-Bhargava A, Smith E, Pasternak S, Frank A, Chertkow H, Ingram J, Hsiung GR, Brittain R, Tartaglia C, Cohen S, Villa LM, Gordon E, Jubault T, Guizard N, Tucker A, Kaufmann WE, Jin K, Chezem WR, Missling CU, Sabbagh MN

The journal of prevention of Alzheimer's disease2025

DOI: 10.1016/j.tjpad.2024.100016 PMID: 39800452

White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases

Ozzoude M, Varriano B, Beaton D, Ramirez J, Adamo S, Holmes MF, Scott CJM, Gao F, Sunderland KM, McLaughlin P

Alzheimer's Research and Therapy202327 citationsOpen Access

DOI: 10.1186/s13195-023-01257-y PMID: W4381433183

Neuropsychiatric Symptom Burden across Neurodegenerative Disorders and its Association with Function

Kapustin D, Zarei S, Wang W, Binns MA, McLaughlin PM, Abrahao A, Black SE, Borrie M, Breen D, Casaubon L

Canadian Journal of Psychiatry202322 citations

DOI: 10.1177/07067437221147443

Rare neurovascular genetic and imaging markers across neurodegenerative diseases

Dilliott AA, Berberian SA, Sunderland KM, Binns MA, Zimmer J, Ozzoude M, Scott CJM, Gao F, Lang AE, Breen DP

Alzheimer's and Dementia20237 citations

DOI: 10.1002/alz.13316

Investigating the contribution of white matter hyperintensities and cortical thickness to empathy in neurodegenerative and cerebrovascular diseases

Ozzoude M, Varriano B, Beaton D, Ramirez J, Holmes MF, Scott CJM, Gao F, Sunderland KM, McLaughlin P, Rabin J

GeroScience20228 citations

DOI: 10.1007/s11357-022-00539-x

Association of apolipoprotein E variation with cognitive impairment across multiple neurodegenerative diagnoses

Dilliott AA, Sunderland KM, McLaughlin PM, Roberts AC, Evans EC, Abrahao A, Binns MA, Black SE, Borrie M, Casaubon LK

Neurobiology of Aging202116 citations

DOI: 10.1016/j.neurobiolaging.2021.04.011

Comparison of Behavior-Related Features in the MMSE Sentence in Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease.

Ruiz-Garcia R, Yu S, Richardson L, Roberts A, Pasternak S, Stewart C, Finger E

Frontiers in aging neuroscience2021

DOI: 10.3389/fnagi.2021.733153 PMID: 34531737

Financial capacity in frontotemporal dementia and related presentations.

Gill S, Blair M, Kershaw M, Jesso S, MacKinley J, Coleman K, Pantazopoulos K, Pasternak S, Finger E

Journal of neurology2019

DOI: 10.1007/s00415-019-09317-w PMID: 31011799

Oxytocin for frontotemporal dementia: a randomized dose-finding study of safety and tolerability.

Finger EC, MacKinley J, Blair M, Oliver LD, Jesso S, Tartaglia MC, Borrie M, Wells J, Dziobek I, Pasternak S, Mitchell DG, Rankin K, Kertesz A, Boxer A

Neurology2015

DOI: 10.1212/wnl.0000000000001133 PMID: 25503617

Profile data last refreshed on November 9, 2025 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Stephen Pasternak

Research

Latest papers

Latest funding

Regional free-water diffusion is more strongly related to neuroinflammation than neurodegeneration

Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial.

White matter hyperintensities and smaller cortical thickness are associated with neuropsychiatric symptoms in neurodegenerative and cerebrovascular diseases

Neuropsychiatric Symptom Burden across Neurodegenerative Disorders and its Association with Function

Rare neurovascular genetic and imaging markers across neurodegenerative diseases

Investigating the contribution of white matter hyperintensities and cortical thickness to empathy in neurodegenerative and cerebrovascular diseases

Association of apolipoprotein E variation with cognitive impairment across multiple neurodegenerative diagnoses

Comparison of Behavior-Related Features in the MMSE Sentence in Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease.

Financial capacity in frontotemporal dementia and related presentations.

Oxytocin for frontotemporal dementia: a randomized dose-finding study of safety and tolerability.

Frequent collaborators

Elizabeth Finger

Michael Borrie

Gustavo Saposnik

Andrew Frank

Dar Dowlatshahi

David Grimes

Sanjeev Kumar

Demetrios Sahlas

Mario Masellis

Connie Marras

John Turnbull

Angela Roberts

Dallas Seitz

Robert Bartha

Ekaterina Rogaeva

Maged Goubran

Manuel Montero Odasso

Jennifer Rabin

Marvin Chum

Malcolm Binns

Michael Borrie

Howard Chertkow

Anthony Lang

Wei Wang

Howard Chertkow

Adam Boxer

Brian Levine

Eric Smith

Tarek Rajji